Table 4. .
Expression of RPS19 mRNA in Human Tissues[Note]
| Human Tissue | RPS19 Average CT | GAPDH Average CT | ΔCT RPS19 − GAPDH | RPS19 Normalized to GAPDH (2-ΔCT) |
| Fetal liver | 22.42 ± .17 | 20.30 ± .10 | 2.13 ± .20 | .23 (.20–.26) |
| Fetal brain | 19.41 ± .10 | 19.96 ± .04 | −.55 ± .10 | 1.46 (1.36–1.57) |
| Brain (cerebellum) | 20.80 ± .25 | 18.36 ± .26 | 2.44 ± .36 | .18 (.14–.24) |
| Brain (whole) | 23.99 ± .20 | 18.94 ± .26 | 5.05 ± .33 | .03 (.02–.04) |
| Thymus | 20.10 ± .19 | 19.97 ± .16 | .13 ± .24 | .91 (.77–1.08) |
| Salivary gland | 21.06 ± .14 | 20.42 ± .09 | .64 ± .17 | .64 (.57–.72) |
| Adrenal gland | 20.69 ± .28 | 20.33 ± .08 | .37 ± .29 | .78 (.63–.95) |
| Thyroid | 20.24 ± .13 | 20.64 ± .23 | −.40 ± .26 | 1.32 (1.10–1.58) |
| Skeletal muscles | 22.66 ± .48 | 17.42 ± .39 | 5.23 ± .62 | .03 (.02–.04) |
| Lung | 20.96 ± .10 | 21.28 ± .04 | −.31 ± .11 | 1.24 (1.15–1.34) |
| Bone marrow | 20.73 ± .22 | 20.34 ± .06 | .38 ± .23 | .77 (.65–.90) |
| Trachea | 21.60 ± .29 | 20.81 ± .27 | .79 ± .39 | .58 (.44–.76) |
| Spinal cord | 20.95 ± .31 | 19.22 ± .08 | 1.73 ± .32 | .30 (.24–.38) |
| Placenta | 20.51 ± .18 | 20.71 ± .22 | −.20 ± .28 | 1.15 (.94–1.40) |
| Heart | 23.39 ± .33 | 18.50 ± .17 | 4.89 ± .37 | .03 (.03–.04) |
| Uterus | 21.36 ± .22 | 20.93 ± .07 | .43 ± .23 | .74 (.63–.87) |
| Testis | 20.81 ± .19 | 19.96 ± .15 | .85 ± .24 | .56 (.47–.66) |
| Prostate | 20.72 ± .14 | 20.77 ± .07 | −.05 ± .16 | 1.04 (.93–1.15) |
| Kidney | 22.78 ± .16 | 19.00 ± .19 | 3.78 ± .24 | .07 (.06–.09) |
Note.— CT = number of quantitative PCR cycles.